Adipose tissue and adrenal glands: Novel pathophysiological mechanisms and clinical applications

International Journal of Endocrinology

Volumn 2014, Issue , 2014, Pages

  Kargi, Atil Y ^a   Iacobellis, Gianluca ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ALDOSTERONE; CATECHOLAMINE; GLUCOCORTICOID; HYDROCORTISONE; MINERALOCORTICOID; MINERALOCORTICOID RECEPTOR;

ADIPOCYTE; ADIPOSE TISSUE; ADRENAL CORTEX ADENOMA; ADRENAL DISEASE; ADRENAL FUNCTION; ADRENAL MEDULLA; BROWN ADIPOSE TISSUE; CORTICOSTEROID METABOLISM; DISEASE ASSOCIATION; HORMONE BINDING; HUMAN; HYPERALDOSTERONISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PROTEIN INTERACTION; REVIEW;

EID: 84903589917     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2014/614074     Document Type: Review

References (84)

1. Addison T., On the constitutional and local effects of disease of the suprarenal capsule. A Collection of the Published Writings of the Late Thomas Addison MD 1868 London, UK New Sydenham Society
2. Oliver G., Schäfer E. A., On the physiological action of extract of the suprarenal capsules. The Journal of Physiology 1895 18 3 230 276
3. Armani A., Mammi C., Marzolla V., Calanchini M., Antelmi A., Rosano G. M. C., Fabbri A., Caprio M., Cellular models for understanding adipogenesis, adipose dysfunction, and obesity. Journal of Cellular Biochemistry 2010 110 3 564 572 2-s2.0-77952690894 10.1002/jcb.22598
4. Berg A. H., Scherer P. E., Adipose tissue, inflammation, and cardiovascular disease. Circulation Research 2005 96 9 939 949 2-s2.0-19044393872 10.1161/01.RES.0000163635.62927.34 (Pubitemid 40712793)
5. Kershaw E. E., Flier J. S., Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology and Metabolism 2004 89 6 2548 2556 2-s2.0-2942650969 10.1210/jc.2004-0395 (Pubitemid 38766330)
6. Lee M., Wu Y., Fried S. K., Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications. Molecular Aspects of Medicine 2013 34 1 1 11 2-s2.0-84872144478 10.1016/j.mam.2012.10.001
7. Trujillo M. E., Scherer P. E., Adipose tissue-derived factors: impact on health and disease. Endocrine Reviews 2006 27 7 762 778 2-s2.0-33845592201 10.1210/er.2006-0033 (Pubitemid 44936059)
8. Han C. Y., Kargi A. Y., Omer M., Chan C. K., Wabitsch M., O'Brien K. D., Wight T. N., Chait A., Differential effect of saturated and unsaturated free fatty acids on the generation of monocyte adhesion and chemotactic factors by adipocytes: dissociation of adipocyte hypertrophy from inflammation. Diabetes 2010 59 2 386 396 2-s2.0-77449092780 10.2337/db09-0925
9. Ronconi V., Turchi F., Bujalska I. J., Giacchetti G., Boscaro M., Adipose cell-adrenal interactions: current knowledge and future perspectives. Trends in Endocrinology and Metabolism 2008 19 3 100 103 2-s2.0-41149133025 10.1016/j.tem.2008.01.004 (Pubitemid 351442918)
10. Paschke L., Zemleduch T., Rucinski M., Ziolkowska A., Szyszka M., Malendowicz L. K., Adiponectin and adiponectin receptor system in the rat adrenal gland: ontogenetic and physiologic regulation, and its involvement in regulating adrenocortical growth and steroidogenesis. Peptides 2010 31 9 1715 1724 2-s2.0-77955654730 10.1016/j.peptides.2010.06.007
11. Bornstein S. R., Uhlmann K., Haidan A., Ehrhart-Bornstein M., Scherbaum W. A., Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland: leptin inhibits cortisol release directly. Diabetes 1997 46 7 1235 1238 2-s2.0-0030919919 (Pubitemid 27271088)
12. Ehrhart-Bornstein M., Lamounier-Zepter V., Schraven A., Langenbach J., Willenberg H. S., Barthel A., Hauner H., McCann S. M., Scherbaum W. A., Bornstein S. R., Human adipocytes secrete mineralocorticoid-releasing factors. Proceedings of the National Academy of Sciences of the United States of America 2003 100 2 14211 14216 2-s2.0-10744220710 10.1073/pnas.2336140100 (Pubitemid 37499216)
13. Funder J. W., Mineralocorticoid receptors: distribution and activation. Heart Failure Reviews 2005 10 1 15 22 2-s2.0-21244485815 10.1007/s10741-005- 2344-2 (Pubitemid 40895312)
14. Zennaro M., Caprio M., Fève B., Mineralocorticoid receptors in the metabolic syndrome. Trends in Endocrinology and Metabolism 2009 20 9 444 451 2-s2.0-72149099639 10.1016/j.tem.2009.05.006
15. Hirata A., Maeda N., Hiuge A., Hibuse T., Fujita K., Okada T., Kihara S., Funahashi T., Shimomura I., Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice. Cardiovascular Research 2009 84 1 164 172 2-s2.0-70449718904 10.1093/cvr/cvp191
16. Funder J. W., Pearce P. T., Smith R., Smith A. I., Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 1988 242 4878 583 585 2-s2.0-0023743171 (Pubitemid 18263202)
17. Feraco A., Armani A., Mammi C., Fabbri A., Rosano G. M. C., Caprio M., Role of mineralocorticoid receptor and renin-angiotensin-aldosterone system in adipocyte dysfunction and obesity. Journal of Steroid Biochemistry and Molecular Biology 2013 137 99 106 2-s2.0-84874783304 10.1016/j.jsbmb.2013.02.012
18. Goodfriend T. L., Ball D. L., Egan B. M., Campbell W. B., Nithipatikom K., Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion. Hypertension 2004 43 2 358 363 2-s2.0-0842333052 10.1161/01.HYP.0000113294. 06704.64 (Pubitemid 38174139)
19. Briones A. M., Cat A. N. D., Callera G. E., Yogi A., Burger D., He Y., Corrêa J. W., Gagnon A. M., Gomez-Sanchez C. E., Gomez-Sanchez E. P., Sorisky A., Ooi T. C., Ruzicka M., Burns K. D., Touyz R. M., Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction. Hypertension 2012 59 5 1069 1078 2-s2.0-84860226019 10.1161/HYPERTENSIONAHA.111.190223
20. Guo C., Ricchiuti V., Lian B. Q., Yao T. M., Coutinho P., Romero J. R., Li J., Williams G. H., Adler G. K., Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor- γ and proinflammatory adipokines. Circulation 2008 117 17 2253 2261 2-s2.0-44049097881 10.1161/CIRCULATIONAHA.107. 748640
21. Gerstein H. C., Yusuf S., Mann J. F. E., Hoogwerf B., Zinman B., Held C., Fisher M., Wolffenbuttel B., Bosch J., Richardson L., Pogue J., Halle J.-P., Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. The Lancet 2000 355 9200 253 259 2-s2.0-0034700790 10.1016/S0140-6736(99)12323-7 (Pubitemid 30068516)
22. Pitt B., Zannad F., Remme W. J., Cody R., Castaigne A., Perez A., Palensky J., Wittes J., The effect of spironolactone on morbidity and mortality in patients with severe heart failure. The New England Journal of Medicine 1999 341 10 709 717 2-s2.0-0033517302 10.1056/NEJM199909023411001 (Pubitemid 29407370)
23. Pitt B., Remme W., Zannad F., Neaton J., Martinez F., Roniker B., Bittman R., Hurley S., Kleiman J., Gatlin M., Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. The New England Journal of Medicine 2003 348 14 1309 1321 2-s2.0-0037417252 10.1056/NEJMoa030207 (Pubitemid 36384098)
24. Devenport L. D., Goodwin K. G., Hopkins P. M., Continuous infusion of aldosterone: correlates of body weight gain. Pharmacology Biochemistry and Behavior 1985 22 5 707 709 2-s2.0-0021949105 (Pubitemid 15120515)
25. Conn J. W., Knopf R. F., Nesbit R. M., Clinical characteristics of primary aldosteronism from an analysis of 145 cases. The American Journal of Surgery 1964 107 1 159 172 2-s2.0-50549212658
26. Iacobellis G., Petramala L., Cotesta D., Pergolini M., Zinnamosca L., Cianci R., de Toma G., Sciomer S., Letizia C., Adipokines and cardiometabolic profile in primary hyperaldosteronism. Journal of Clinical Endocrinology and Metabolism 2010 95 5 2391 2398 2-s2.0-77952752920 10.1210/jc.2009-2204
27. Peckett A. J., Wright D. C., Riddell M. C., The effects of glucocorticoids on adipose tissue lipid metabolism. Metabolism: Clinical and Experimental 2011 60 11 1500 1510 2-s2.0-80054986457 10.1016/j.metabol.2011.06. 012
28. Lee M., Pramyothin P., Karastergiou K., Fried S. K., Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity. Biochimica et Biophysica Acta: Molecular Basis of Disease 2014 1842 3 473 481 2-s2.0-84878975962 10.1016/j.bbadis.2013.05.029
29. Tomlinson J. J., Boudreau A., Wu D., Atlas E., Haché R. J. G., Modulation of early human preadipocyte differentiation by glucocorticoids. Endocrinology 2006 147 11 5284 5293 2-s2.0-33751200644 10.1210/en.2006-0267 (Pubitemid 44790583)
30. Strack A. M., Bradbury M. J., Dallman M. F., Corticosterone decreases nonshivering thermogenesis and increases lipid storage in brown adipose tissue. American Journal of Physiology: Regulatory Integrative and Comparative Physiology 1995 268 1, part 2 R183 R191 2-s2.0-0028873134
31. Bujalska I. J., Kumar S., Stewart P. M., Does central obesity reflect "Cushing's disease of the omentum"? The Lancet 1997 349 9060 1210 1213 2-s2.0-0030936556 (Pubitemid 27190044)
32. Caprio M., Fève B., Claës A., Viengchareun S., Lombès M., Zennaro M., Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis. FASEB Journal 2007 21 9 2185 2194 2-s2.0-34347406538 10.1096/fj.06-7970com (Pubitemid 47026453)
33. Morton N., Seckl J., 11 β -hydroxysteroid dehydrogenase type 1 and obesity. Frontiers of Hormone Research 2007 36 146 164 2-s2.0-43049122505 10.1159/000115363
34. Purnell J. Q., Kahn S. E., Samuels M. H., Brandon D., Loriaux D. L., Brunzell J. D., Enhanced cortisol production rates, free cortisol, and 11 β -HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss. American Journal of Physiology: Endocrinology and Metabolism 2009 296 2 E351 E357 2-s2.0-60849127882 10.1152/ajpendo.90769.2008
35. Masuzaki H., Yamamoto H., Kenyon C. J., Elmquist J. K., Morton N. M., Paterson J. M., Shinyama H., Sharp M. G. F., Fleming S., Mullins J. J., Seckl J. R., Flier J. S., Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. Journal of Clinical Investigation 2003 112 1 83 90 2-s2.0-0041302382 10.1172/JCI200317845 (Pubitemid 38056379)
36. Wamil M., Seckl J. R., Inhibition of 11ß-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target. Drug Discovery Today 2007 12 13-14 504 520 2-s2.0-34447105433 10.1016/j.drudis.2007.06.001 (Pubitemid 47031664)
37. Pereira C. D., Azevedo I., Monteiro R., Martins M. J., 11 β -hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus. Diabetes, Obesity and Metabolism 2012 14 10 869 881 2-s2.0-84865975344 10.1111/j.1463-1326.2012.01582.x
38. Hollis G., Huber R., 11 β -hydroxysteroid dehydrogenase type 1 inhibition in type 2 diabetes mellitus. Diabetes, Obesity and Metabolism 2011 13 1 1 6 2-s2.0-78649719548 10.1111/j.1463-1326.2010.01305.x
39. Rosenstock J., Banarer S., Fonseca V. A., Inzucchi S. E., William S., Wenqing Y., Hollis G., Flores R., Levy R., Williams W. V., Seckl J. R., Huber R., The 11- β -hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy. Diabetes Care 2010 33 7 1516 1522 2-s2.0-77955630861 10.2337/dc09-2315
40. Lee M., Gong D., Burkey B. F., Fried S. K., Pathways regulated by glucocorticoids in omental and subcutaneous human adipose tissues: a microarray study. American Journal of Physiology: Endocrinology and Metabolism 2011 300 3 E571 E580 2-s2.0-79952171366 10.1152/ajpendo.00231.2010
41. Lee M., Fried S. K., Integration of hormonal and nutrient signals that regulate leptin synthesis and secretion. American Journal of Physiology: Endocrinology and Metabolism 2009 296 6 E1230 E1238 2-s2.0-66849138498 10.1152/ajpendo.90927.2008
42. Sukumaran S., DuBois D. C., Jusko W. J., Almon R. R., Glucocorticoid effects on adiponectin expression. Vitamins and Hormones 2012 90 163 186 2-s2.0-84866607442 10.1016/B978-0-12-398313-8.00007-5
43. Pasquali R., Vicennati V., Cacciari M., Pagotto U., The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome. Annals of the New York Academy of Sciences 2006 1083 111 128 2-s2.0-33845667299 10.1196/annals.1367.009 (Pubitemid 44955469)
44. Vicennati V., Ceroni L., Gagliardi L., Pagotto U., Gambineri A., Genghini S., Pasquali R., Response of the hypothalamic-pituitary-adrenal axis to small dose arginine-vasopressin and daily urinary free cortisol before and after alprazolam pre-treatment differs in obesity. Journal of Endocrinological Investigation 2004 27 6 541 547 2-s2.0-4544377737 (Pubitemid 39255504)
45. Bertagna X., Coste J., Raux-Demay M. C., Letrait M., Strauch G., The combined corticotropin-releasing hormone/lysine vasopressin test discloses a corticotroph phenotype. Journal of Clinical Endocrinology and Metabolism 1994 79 2 390 394 2-s2.0-0027936813 10.1210/jc.79.2.390 (Pubitemid 24256524)
46. Pasquali R., Cantobelli S., Casimirri F., Capelli M., Bortoluzzi L., Flamia R., Labate A. M. M., Barbara L., The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. Journal of Clinical Endocrinology and Metabolism 1993 77 2 341 346 2-s2.0-0027185253 10.1210/jc.77.2.341 (Pubitemid 23230037)
47. Marin P., Darin N., Amemiya T., Andersson B., Jern S., Bjorntorp P., Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism: Clinical and Experimental 1992 41 8 882 886 2-s2.0-0026685047 10.1016/0026-0495(92)90171-6
48. Pasquali R., Ambrosi B., Armanini D., Cavagnini F., Uberti E. D., Rio G. D., de Pergola G., Maccario M., Mantero F., Marugo M., Rotella C. M., Vettor R., Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study. Journal of Clinical Endocrinology and Metabolism 2002 87 1 166 175 2-s2.0-18244405083 10.1210/jc.87.1.166 (Pubitemid 34084687)
49. Orentreich N., Brind J. L., Rizer R. L., Vogelman J. H., Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. Journal of Clinical Endocrinology and Metabolism 1984 59 3 551 555 2-s2.0-0021181906 (Pubitemid 14031806)
50. Feher T., Bodrogi L., A comparative study of steroid concentrations in human adipose tissue and the peripheral circulation. Clinica Chimica Acta 1982 126 2 135 141 2-s2.0-0020370764 10.1016/0009-8981(82)90029-8 (Pubitemid 13247375)
51. Trivedi D. P., Khaw K. T., Dehydroepiandrosterone sulfate and mortality in elderly men and women. Journal of Clinical Endocrinology and Metabolism 2001 86 9 4171 4177 2-s2.0-0034857561 10.1210/jc.86.9.4171 (Pubitemid 32848531)
52. Rice S. P. L., Zhang L., Grennan-Jones F., Agarwal N., Lewis M. D., Rees D. A., Ludgate M., Dehydroepiandrosterone (DHEA) treatment in vitro inhibits adipogenesis in human omental but not subcutaneous adipose tissue. Molecular and Cellular Endocrinology 2010 320 1-2 51 57 2-s2.0-77949570155 10.1016/j.mce.2010.02.017
53. Hernandez-Morante J. J., Milagro F., Gabaldon J. A., Martinez J. A., Zamora S., Garaulet M., Effect of DHEA-sulfate on adiponectin gene expression in adipose tissue from different fat depots in morbidly obese humans. European Journal of Endocrinology 2006 155 4 593 600 2-s2.0-33750254204 10.1530/eje.1.02256 (Pubitemid 44608433)
54. Kochan Z., Karbowska J., Dehydroepiandrosterone up-regulates resistin gene expression in white adipose tissue. Molecular and Cellular Endocrinology 2004 218 1-2 57 64 2-s2.0-2342584138 10.1016/j.mce.2003.12.012 (Pubitemid 38569927)
55. Tchernof A., Labrie F., Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies. European Journal of Endocrinology 2004 151 1 1 14 2-s2.0-4344576898 10.1530/eje.0.1510001 (Pubitemid 39117360)
56. Villareal D. T., Holloszy J. O., Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial. Journal of the American Medical Association 2004 292 18 2243 2248 2-s2.0-7744230247 10.1001/jama.292.18.2243 (Pubitemid 39473162)
57. Mayes J. S., Watson G. H., Direct effects of sex steroid hormones on adipose tissues and obesity. Obesity Reviews 2004 5 4 197 216 2-s2.0-7044250697 10.1111/j.1467-789X.2004.00152.x (Pubitemid 39423001)
58. Ramirez M. E., McMurry M. P., Wiebke G. A., Felten K. J., Ren K., Meikle A. W., Iverius P., Evidence for sex steroid inhibition of lipoprotein lipase in men: comparison of abdominal and femoral adipose tissue. Metabolism: Clinical and Experimental 1997 46 2 179 185 2-s2.0-0031048003 10.1016/S0026-0495(97) 90299-7 (Pubitemid 27078764)
59. Brann D. W., de Sevilla L., Zamorano P. L., Mahesh V. B., Regulation of leptin gene expression and secretion by steroid hormones. Steroids 1999 64 9 659 663 2-s2.0-0032833320 10.1016/S0039-128X(99)00049-5 (Pubitemid 29424106)
60. Arner P., Catecholamine-induced lipolysis in obesity. International Journal of Obesity 1999 23 supplement 1 10 13 2-s2.0-0032990467 (Pubitemid 29101370)
61. Jocken J. W. E., Blaak E. E., Catecholamine-induced lipolysis in adipose tissue and skeletal muscle in obesity. Physiology and Behavior 2008 94 2 219 230 2-s2.0-42949140834 10.1016/j.physbeh.2008.01.002 (Pubitemid 351615431)
62. Than A., Ye F., Xue R., Ong J. W., Poh C. L., Chen P., The crosstalks between adipokines and catecholamines. Molecular and Cellular Endocrinology 2011 332 1-2 261 270 2-s2.0-78650524122 10.1016/j.mce.2010.11.002
63. Dulloo A. G., A sympathetic defense against obesity. Science 2002 297 5582 780 781 2-s2.0-0037008480 10.1126/science.1074923 (Pubitemid 34839615)
64. Smith M. M., Minson C. T., Obesity and adipokines: effects on sympathetic overactivity. Journal of Physiology 2012 590 8 1787 1801 2-s2.0-84859721989 10.1113/jphysiol.2011.221036
65. Simonds S. E., Cowley M. A., Enriori P. J., Leptin increasing sympathetic nerve outflow in obesity: a cure for obesity or a potential contributor to metabolic syndrome? Adipocyte 2012 1 3 177 181 10.4161/adip.20690
66. Böttner A., Eisenhofer G., Torpy D. J., Ehrhart-Bornstein M., Keiser H. R., Chrousos G. P., Bornstein S. R., Preliminary report: lack of leptin suppression in response to hypersecretion of catecholamines in pheochromocytoma patients. Metabolism: Clinical and Experimental 1999 48 5 543 545 2-s2.0-0033128888 10.1016/S0026-0495(99)90047-1 (Pubitemid 29230510)
67. Kuji I., Imabayashi E., Minagawa A., Matsuda H., Miyauchi T., Brown adipose tissue demonstrating intense FDG uptake in a patient with mediastinal pheochromocytoma. Annals of Nuclear Medicine 2008 22 3 231 235 2-s2.0-44349084943 10.1007/s12149-007-0096-x (Pubitemid 351729626)
68. Iyer R. B., Guo C. C., Perrier N., Adrenal pheochromocytoma with surrounding brown fat stimulation. American Journal of Roentgenology 2009 192 1 300 301 2-s2.0-58149239945 10.2214/AJR.08.1166
69. Iacobellis G., di Gioia C., Petramala L., Brown fat expresses adiponectin in humans. International Journal of Endocrinology 2013 2013 6 126751 10.1155/2013/126751
70. Zeiger M. A., Siegelman S. S., Hamrahian A. H., Medical and surgical evaluation and treatment of adrenal incidentalomas. Journal of Clinical Endocrinology and Metabolism 2011 96 7 2004 2015 2-s2.0-79960089147 10.1210/jc.2011-0085
71. Terzolo M., Pia A., Alì A., Osella G., Reimondo G., Bovio S., Daffara F., Procopio M., Paccotti P., Borretta G., Angeli A., Adrenal incidentaloma: a new cause of the metabolic syndrome? Journal of Clinical Endocrinology and Metabolism 2002 87 3 998 1003 2-s2.0-0036959742 10.1210/jc.87.3.998 (Pubitemid 36121054)
72. Iacobellis G., Petramala L., Barbaro G., Kargi A. Y., Serra V., Zinnamosca L., Colangelo L., Marinelli C., Ciardi A., de Toma G., Letizia C., Epicardial fat thickness and left ventricular mass in subjects with adrenal incidentaloma. Endocrine 2013 44 2 532 536 2-s2.0-84873951267 10.1007/s12020-013-9902-5
73. Peppa M., Boutati E., Koliaki C., Papaefstathiou N., Garoflos E., Economopoulos T., Hadjidakis D., Raptis S. A., Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: a cause-effect relationship? Metabolism: Clinical and Experimental 2010 59 10 1435 1441 2-s2.0-77956947843 10.1016/j.metabol.2010.01.007
74. Reincke M., Faßnacht M., Väth S., Mora P., Allolio B., Adrenal incidentalomas: a manifestation of the metabolic syndrome? Endocrine Research 1996 22 4 757 761 2-s2.0-0030447507 (Pubitemid 26424404)
75. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J. M., Positional cloning of the mouse obese gene and its human homologue. Nature 1994 372 6505 425 432 2-s2.0-0028139089 10.1038/372425a0 (Pubitemid 24365442)
76. Kruse M., Bornstein S. R., Uhlmann K., Paeth G., Scherbaum W. A., Leptin down-regulates the steroid producing system in the adrenal. Endocrine Research 1998 24 3-4 587 590 2-s2.0-0032440939 (Pubitemid 29016442)
77. Pralong F. P., Roduit R., Waeber G., Castillo E., Mosimann F., Thorens B., Gaillard R. C., Leptin inhibits directly glucocorticoid secretion by normal human and rat adrenal gland. Endocrinology 1998 139 10 4264 4268 2-s2.0-0031734449 (Pubitemid 28513714)
78. Heiman M. L., Ahima R. S., Craft L. S., Schoner B., Stephens T. W., Flier J. S., Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology 1997 138 9 3859 3863 2-s2.0-0030855190 10.1210/en.138.9.3859 (Pubitemid 27351940)
79. Lado-Abeal J., Mrotek J. J., Stocco D. M., Norman R. L., Effect of leptin on ACTH-stimulated secretion of cortisol in rhesus macaques and on human adrenal carcinoma cells. European Journal of Endocrinology 1999 141 5 534 538 2-s2.0-0032718670
80. Takekoshi K., Motooka M., Isobe K., Nomura F., Manmoku T., Ishii K., Nakai T., Leptin directly stimulates catecholamine secretion and synthesis in cultured porcine adrenal medullary chromaffin cells. Biochemical and Biophysical Research Communications 1999 261 2 426 431 2-s2.0-0033517005 10.1006/bbrc.1999.1025 (Pubitemid 29392492)
81. Rossi G. P., Sticchi D., Giuliani L., Bernante P., Zavattiero S., Pessina A. C., Nussdorfer G. G., Adiponectin receptor expression in the human adrenal cortex and aldosterone-producing adenomas. International Journal of Molecular Medicine 2006 17 6 975 980 2-s2.0-33745713610
82. Li P., Sun F., Cao H., Ma Q., Pan C., Ma J., Zhang X., Jiang H., Song H., Chen M., Expression of adiponectin receptors in mouse adrenal glands and the adrenocortical Y-1 cell line: adiponectin regulates steroidogenesis. Biochemical and Biophysical Research Communications 2009 390 4 1208 1213 2-s2.0-70549101137 10.1016/j.bbrc.2009.10.122
83. Degawa-Yamauchi M., Moss K. A., Bovenkerk J. E., Shankar S. S., Morrison C. L., Lelliott C. J., Vidal-Puig A., Jones R., Considine R. V., Regulation of adiponectin expression in human adipocytes: effects of adiposity, glucocorticoids, and tumor necrosis factor α Obesity Research 2005 13 4 662 669 2-s2.0-24044451713
84. Iwen K. A. H., Senyaman O., Schwartz A., Drenckhan M., Meier B., Hadaschik D., Klein J., Melanocortin crosstalk with adipose functions: ACTH directly induces insulin resistance, promotes a pro-inflammatory adipokine profile and stimulates UCP-1 in adipocytes. Journal of Endocrinology 2008 196 3 465 472 2-s2.0-41149092168 10.1677/JOE-07-0299 (Pubitemid 351425502)